HLA-B27-Associated Reactive Arthritis: Pathogenetic and Clinical Considerations
暂无分享,去创建一个
[1] M. Leirisalo-Repo,et al. Long term prognosis of reactive salmonella arthritis , 1997, Annals of the rheumatic diseases.
[2] T. Salo,et al. In vivo inhibition of human neutrophil collagenase (MMP‐8) activity during long‐term combination therapy of doxycycline and non‐steroidal anti‐inflammatory drugs (NSAID) in acute reactive arthritis , 1994, Clinical and experimental immunology.
[3] M. De Vos,et al. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. , 1985, The Journal of rheumatology.
[4] A. Calin,et al. Reiter's syndrome following epidemic shigellosis. , 1981, The Journal of rheumatology.
[5] G. Covell. Chemotherapy of Malaria , 1964 .
[6] A. McMichael,et al. Multiple T cell expansions are found in the blood and synovial fluid of patients with reactive arthritis. , 1997, The Journal of rheumatology.
[7] Andreas Radbruch,et al. Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. , 1999, Arthritis and rheumatism.
[8] G. Alarcón,et al. Reactive arthritis in patients attending an urban sexually transmitted diseases clinic. , 1996, Arthritis and rheumatism.
[9] J. Taurog. Arthritis in HLA-B27 transgenic animals. , 1998, The American journal of the medical sciences.
[10] H. Isomäki,et al. Incidence of inflammatory rheumatic diseases in Finland. , 1978, Scandinavian journal of rheumatology.
[11] J. Braun,et al. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? , 1995, Arthritis and rheumatism.
[12] R. Inman,et al. Postdysenteric reactive arthritis , 1988 .
[13] L. V. D. van de Putte,et al. Second-line treatment in seronegative spondylarthropathies. , 1994, Seminars in arthritis and rheumatism.
[14] T. Möttönen,et al. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis , 2003 .
[15] B. Krausse-Opatz,et al. Infection of Human Monocyte-Derived Macrophages with Chlamydia trachomatis Induces Apoptosis of T Cells: a Potential Mechanism for Persistent Infection , 2000, Infection and Immunity.
[16] J. Kuipers,et al. Role of bacteria and HLA-B27 in the pathogenesis of reactive arthritis. , 2003, Rheumatic diseases clinics of North America.
[17] G. Panayi,et al. Minocycline in the treatment of patients with Reiter's syndrome. , 1989, Clinical and experimental rheumatology.
[18] E. Lally,et al. A review of methotrexate therapy in Reiter syndrome. , 1985, Seminars in arthritis and rheumatism.
[19] S. Ehlers,et al. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. , 1997, The Journal of rheumatology.
[20] H. Locht,et al. Antineutrophil cytoplasmic antibodies in reactive arthritis. , 1995, The Journal of rheumatology.
[21] E. Hay. Reiter's syndrome and reactive arthritis. , 1991, British journal of rheumatology.
[22] K. Krogfelt,et al. Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli , 2002, Annals of the rheumatic diseases.
[23] H. Gérard,et al. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. , 1998, The Journal of rheumatology.
[24] J. Braun,et al. Rheumatologic manifestations of gastrointestinal disorders. , 1999, Current opinion in rheumatology.
[25] T. Elliott,et al. Lymphoblastoid cells express HLA‐B27 homodimers both intracellularly and at the cell surface following endosomal recycling , 2003, European journal of immunology.
[26] H. Doerr,et al. Testing for Chlamydia trachomatis in urine , 1997, The Lancet.
[27] M. Leirisalo-Repo,et al. Chlamydia pneumoniae as a triggering infection in reactive arthritis. , 1999, Rheumatology.
[28] T. Kvien,et al. Reactive arthritis: incidence, triggering agents and clinical presentation. , 1994, The Journal of rheumatology.
[29] P. Toivanen. From reactive arthritis to rheumatoid arthritis. , 2001, Journal of autoimmunity.
[30] T. Vischer,et al. The value of isotype determination of serum antibodies against Chlamydia for the diagnosis of Chlamydia reactive arthritis. , 1996, British journal of rheumatology.
[31] H. Schumacher. How micro-organisms are handled to localize to joints and within joints. , 1995, Scandinavian journal of rheumatology. Supplement.
[32] Hanschell,et al. MEDICAL SOCIETY FOR THE STUDY OF VENEREAL DISEASES. , 1922 .
[33] T. Kvien,et al. Prediction of diagnosis in acute and subacute oligoarthritis of unknown origin. , 1996, British journal of rheumatology.
[34] S. Jalkanen,et al. Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. , 1992, The Journal of rheumatology.
[35] G. Lathrop,et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. , 1992, Arthritis and rheumatism.
[36] R. Terkeltaub,et al. Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. , 1992, Journal of immunology.
[37] S. Jalkanen,et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis , 1990, The Lancet.
[38] D. Reda,et al. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. , 1999, Arthritis and rheumatism.
[39] C. Eastmond,et al. An outbreak of Campylobacter enteritis--a rheumatological followup survey. , 1983, The Journal of rheumatology.
[40] A. Hudson,et al. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. , 1995, Arthritis and rheumatism.
[41] A. Poole. The histopathology of ankylosing spondylitis: are there unifying hypotheses? , 1998, The American journal of the medical sciences.
[42] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[43] J. Vácha,et al. Sulphasalazine in the treatment of reactive arthritis. , 1987, Scandinavian journal of rheumatology. Supplement.
[44] A. Siitonen,et al. Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection. , 1998, The Journal of infection.
[45] M. Leirisalo-Repo. Therapeutic aspects of spondyloarthropathies -- a review. , 1998, Scandinavian Journal of Rheumatology.
[46] K. Granfors,et al. Salmonella-triggered reactive arthritis , 1992, The Lancet.
[47] Andrej Tarkowski,et al. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis , 1999, Nature Medicine.
[48] T. Vischer,et al. Different humoral immune response to Chlamydia trachomatis major outer membrane protein variable domains I and IV in Chlamydia-infected patients with or without reactive arthritis. , 1999, Arthritis and rheumatism.
[49] B. Thomas,et al. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction , 1992, The Lancet.
[50] E. Hulse,et al. COLUMBUS: WAS IT REITER'S DISEASE? , 1981, The Lancet.
[51] P. Bowness. HLA B27 in health and disease: a double-edged sword? , 2002, Rheumatology.
[52] H. Zeidler,et al. Chlamydial rRNA in the joints of patients with Chlamydia-induced arthritis and undifferentiated arthritis. , 1992, Clinical and experimental rheumatology.
[53] J. Pearce,et al. Identification and characterization of a DR4‐restricted T cell epitope within chlamydia heat shock protein 60 , 1997, Clinical and experimental immunology.
[54] R. Lahesmaa,et al. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. , 1998, Arthritis and rheumatism.
[55] W. Beatty,et al. Reactivation of persistent Chlamydia trachomatis infection in cell culture , 1995, Infection and immunity.
[56] T. Möttönen,et al. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis , 2000, Annals of the rheumatic diseases.
[57] D K FORD,et al. Reiter's syndrome , 1981 .
[58] J. Heesemann,et al. Infection of Synovial Fibroblasts in Culture by Yersinia enterocolitica and Salmonella enterica Serovar Enteritidis: Ultrastructural Investigation with Respect to the Pathogenesis of Reactive Arthritis , 2001, Infection and Immunity.
[59] S. Jalkanen,et al. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms , 1995, The Journal of experimental medicine.
[60] M. Leirisalo-Repo. Prognosis, course of disease, and treatment of the spondyloarthropathies. , 1998, Rheumatic diseases clinics of North America.
[61] P. Saikku,et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. , 1991, Arthritis and rheumatism.
[62] J. Woodward,et al. Yersinia enterocolitica produces superantigenic activity. , 1992, Journal of immunology.
[63] P. Emery,et al. Classification of inflammatory arthritis by enthesitis , 1998, The Lancet.
[64] H. Gérard,et al. Comparison of synovial tissue and synovial fluid as the source of nucleic acids for detection of Chlamydia trachomatis by polymerase chain reaction. , 1996, Arthritis and rheumatism.
[65] T. Vischer,et al. Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis. , 1998, British journal of rheumatology.
[66] J. Braun,et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. , 1998, Arthritis and rheumatism.
[67] M. Skurnik,et al. The Evolutionarily Conserved Ribosomal Protein L23 and the Cationic Urease β-Subunit of Yersinia enterocolitica O:3 Belong to the Immunodominant Antigens in Yersinia-Triggered Reactive Arthritis: Implications for Autoimmunity , 1994, Molecular medicine.
[68] Del valle Gutiérrez Fj,et al. [Reiter's syndrome]. , 1977 .
[69] K. Granfors,et al. Infectious agents as triggers of reactive arthritis. , 1998, The American journal of the medical sciences.
[70] M. Leirisalo-Repo,et al. Modulation of peripheral blood mononuclear cell activation status during Salmonella-triggered reactive arthritis. , 1999, Arthritis and rheumatism.
[71] I. Bjarnason,et al. Inflammatory bowel disease and spondylarthropathy. , 2001, Arthritis and rheumatism.
[72] L. Pelliniemi,et al. HLA‐B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells , 1997, European journal of immunology.
[73] S. Jalkanen,et al. Human Leukocyte Subpopulations from Inflamed Gut Bind to Joint Vasculature Using Distinct Sets of Adhesion Molecules1 , 2001, The Journal of Immunology.
[74] K. Cann. Principles and practice of infectious disease , 1990 .
[75] J. Vartiainen,et al. ARTHRITIS DUE TO SALMONELLA TYPHIMURIUM. REPORT OF 12 CASES OF MIGRATORY ARTHRITIS IN ASSOCIATION WITH SALMONELLA TYPHIMURIUM INFECTION. , 2009, Acta medica Scandinavica.
[76] P. Lipsky,et al. Association between reactive arthritis and antecedent infection with Shigella flexneri carrying a 2-Md plasmid and encoding an HLA-B27 mimetic epitope. , 1993, Arthritis and rheumatism.
[77] M. Skurnik,et al. Bacterial PCR in the diagnosis of joint infection , 2001, Annals of the rheumatic diseases.
[78] P. Pratsidou-Gertsi,et al. Persistent or severe course of reactive arthritis following Salmonella enteritidis infection. A prospective study of 9 cases. , 1998, Scandinavian journal of rheumatology.
[79] Michael J. Wilson,et al. Cutting Edge: Leukocyte Receptor Complex-Encoded Immunomodulatory Receptors Show Differing Specificity for Alternative HLA-B27 Structures1 , 2001, The Journal of Immunology.
[80] D. Nance,et al. Inhibition of Apoptosis in Chlamydia-infected Cells: Blockade of Mitochondrial Cytochrome c Release and Caspase Activation , 1998, The Journal of experimental medicine.
[81] D. Levitt,et al. The immunobiology of Chlamydia. , 1987, Immunology today.
[82] J. Reveille,et al. HLA-B27 and the seronegative spondyloarthropathies. , 1998, The American journal of the medical sciences.
[83] S. Jalkanen,et al. Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes , 1997, Infection and immunity.
[84] F. Emmrich,et al. Characterization of the binding region for the Yersinia enterocolitica adhesin YadA on types I and II collagen. , 1995, Arthritis and rheumatism.
[85] A. Bubert,et al. Dendritic cell function is perturbed by Yersinia enterocolitica infection in vitro , 2000, Clinical and experimental immunology.
[86] J. Heesemann,et al. Persistence of Yersinia enterocolitica in man , 1988, Infection.
[87] H. Schumacher,et al. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Immunocytochemical identification of chlamydial antigen in patients with early disease. , 1988, Arthritis and rheumatism.
[88] K. Granfors. Do bacterial antigens cause reactive arthritis? , 1992, Rheumatic diseases clinics of North America.
[89] J. Weitzman. Dendritic cell function , 2001, Genome Biology.
[90] P. Wu,et al. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. , 1997, Arthritis and rheumatism.
[91] R. Vuento,et al. In vitro lymphoproliferative response to Yersinia: depressed response in arthritic patients years after Yersinia infection. , 1983, Clinical and experimental rheumatology.
[92] L. Espinoza,et al. Chlamydia-induced reactive arthritis. , 1993, Rheumatic diseases clinics of North America.
[93] H. Kautiainen,et al. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden , 2002, Annals of the rheumatic diseases.
[94] J. Braun,et al. Treatment of reactive arthritis with antibiotics. , 1998, British journal of rheumatology.
[95] L. Latulippe,et al. [Reactive arthritis]. , 1980, L'union medicale du Canada.
[96] D. M. van der Heijde,et al. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial , 1997, Annals of the rheumatic diseases.
[97] J. Harley,et al. A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[98] T. Feltkamp. Factors involved in the pathogenesis of HLA-B27 associated arthritis. , 1995, Scandinavian journal of rheumatology. Supplement.
[99] J. Braun,et al. Pathogenesis of spondylarthropathies , 1995 .
[100] First,et al. Identification of the Yersinia enterocolitica urease beta subunit as a target antigen for human synovial T lymphocytes in reactive arthritis , 1993, Infection and immunity.
[101] H. Rammensee,et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. , 1999, Journal of immunology.
[102] D. Karras,et al. Change in the epidemiology of Reiter's syndrome (reactive arthritis) in the post-AIDS era? An analysis of cases appearing in the Greek Army. , 1995, The Journal of rheumatology.
[103] I. Paronen. Reiter's Disease. A Study of 344 Cases Observed, in Finland. , 1948 .
[104] Ulrich Dobrindt,et al. Prokaryotic Chromosomes and Disease , 2003, Science.
[105] A. Keat. Reiter's syndrome and reactive arthritis in perspective. , 1983, The New England journal of medicine.
[106] F. Wollheim. Enteropathic arthritis: how do the joints talk with the gut? , 2001, Current opinion in rheumatology.
[107] C. Goldsmith,et al. Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis , 2001, Annals of the rheumatic diseases.
[108] J. Braun,et al. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis , 2001, Annals of the rheumatic diseases.
[109] K. Aho,et al. Incidence of chronic inflammatory joint diseases in Finland in 1995. , 2000, The Journal of rheumatology.
[110] L. Laasonen,et al. Antibiotic treatment and long term prognosis of reactive arthritis , 2003, Annals of the rheumatic diseases.
[111] G. Kingsley,et al. Report on the Fourth International Workshop on Reactive Arthritis. , 2000, Arthritis and rheumatism.
[112] R. Inman. Classification criteria for reactive arthritis. , 1999, The Journal of rheumatology.
[113] G. Cornelis,et al. Differential secretion of interleukin-8 by human epithelial cell lines upon entry of virulent or nonvirulent Yersinia enterocolitica , 1996, Infection and immunity.
[114] M. De Vos,et al. Course of gut inflammation in spondylarthropathies and therapeutic consequences. , 1996, Bailliere's clinical rheumatology.
[115] Y. Hirata,et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. , 1995, The Journal of clinical investigation.
[116] T. Möttönen,et al. Salmonella-triggered reactive arthritis: use of polymerase chain reaction, immunocytochemical staining, and gas chromatography-mass spectrometry in the detection of bacterial components from synovial fluid. , 1999, Arthritis and rheumatism.
[117] H. Reiter. Ueber eine bisher unerkannte Spirochäteninfektion (Spirochaetosis arthritica) , 1916 .
[118] M. Ikeda,et al. The pathogenesis of HLA-B27 arthritis: role of HLA-B27 in bacterial defense. , 1998, The American journal of the medical sciences.
[119] Muhammad Asim Khan,et al. Update on Spondyloarthropathies , 2002, Annals of Internal Medicine.
[120] A. McMichael,et al. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. , 1999, Journal of immunology.
[121] E. Braunstein,et al. Radiologic features of Reiter disease. , 1979, Radiology.
[122] S. Prahalad,et al. Predisposing factors in the Spondyloarthropathies: New insights into the role of HLA-B27 , 2001, Current rheumatology reports.
[123] W. V. Van Voorhis,et al. Analysis of lymphocyte phenotype and cytokine activity in the inflammatory infiltrates of the upper genital tract of female macaques infected with Chlamydia trachomatis. , 1996, The Journal of infectious diseases.
[124] W. Tsai,et al. Expression of arthritis-causing HLA-B27 on Hela cells promotes induction of c-fos in response to in vitro invasion by Salmonella typhimurium. , 1998, The Journal of clinical investigation.
[125] R. Lawrence,et al. A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study. Has the classic case misled us? , 1997, Archives of internal medicine.
[126] M. Dougados,et al. Predictive factors for the longterm outcome of spondyloarthropathies. , 1994, The Journal of rheumatology.
[127] A. Toivanen. Managing reactive arthritis. , 2000, Rheumatology.
[128] J. Peterson,et al. Yersinia enterocolitica envelope proteins that are crossreactive with the thyrotropin receptor (TSHR) also have B-cell mitogenic activity. , 1996, Journal of autoimmunity.
[129] M. Dougados,et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. , 1991, Arthritis and rheumatism.
[130] H. Zeidler,et al. Reactive or infectious arthritis , 1999, Annals of the rheumatic diseases.
[131] L. Voipio‐Pulkki,et al. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. , 1982, Arthritis and rheumatism.
[132] D. Wakefield,et al. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. , 1999, Arthritis and rheumatism.
[133] G. Ehrlich. Kelley's Textbook of Rheumatology, 6th ed, CD-ROM , 2002 .
[134] M. De Vos,et al. Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. , 1995, The Journal of rheumatology.
[135] R. Terkeltaub,et al. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. , 1992, The Journal of clinical investigation.
[136] P. Toivanen,et al. Salmonella specific antibodies in serum and synovial fluid in patients with reactive arthritis. , 1992, British journal of rheumatology.
[137] S. Jalkanen,et al. Combination therapy in rheumatoid arthritis. , 1992 .
[138] A. Toivanen,et al. Does Yersinia induce autoimmunity? , 1994, International archives of allergy and immunology.
[139] J. Strominger,et al. Free Heavy Chains of HLA-B2705 on the Cell Surface , 2002 .
[140] J. Sibilia,et al. Reactive arthritis or chronic infectious arthritis? , 2002, La Revue de medecine interne.
[141] H. Zeidler,et al. Detection of Chlamydia trachomatis in peripheral blood leukocytes of reactive arthritis patients by polymerase chain reaction. , 1998, Arthritis and rheumatism.
[142] D. Heijde,et al. Clinical aspects, outcome assessment, and management of ankylosing spondylitis and postenteric reactive arthritis. , 2000 .
[143] G. Kingsley,et al. Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. , 1998, Arthritis and rheumatism.
[144] S. Jalkanen,et al. Increased synovial endothelium binding and transendothelial migration of mononuclear cells during Salmonella infection. , 1998, Arthritis and rheumatism.
[145] B. Amor. Reiter's syndrome. Diagnosis and clinical features. , 1998, Rheumatic diseases clinics of North America.
[146] N. Tsuchiya,et al. Induction of alternative splicing of HLA-B27 by bacterial invasion. , 1997, Arthritis and rheumatism.
[147] P. Greminger,et al. Systemic vasculitis associated with seronegative spondylarthropathy (Reiter's syndrome) , 1997, Clinical Rheumatology.
[148] H. Zeidler,et al. Undifferentiated arthritis and reactive arthritis. , 1998, Current opinion in rheumatology.
[149] S. Wahl,et al. Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators. , 1991, Journal of immunology.
[150] E. Unanue,et al. The basis for the immunoregulatory role of macrophages and other accessory cells. , 1987, Science.
[151] M. Sieck,et al. Light and electron microscopic studies on the synovial membrane in reiter's syndrome. , 1988 .
[152] R. Hammer,et al. Defective dendritic cell (DC) function in a HLA-B27 transgenic rat model of spondyloarthropathy (SpA). , 1995, Advances in experimental medicine and biology.
[153] H. Gérard,et al. Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects. , 1999, Arthritis and rheumatism.
[154] J. Braun,et al. The 19 kDa protein of Yersinia enterocolitica O:3 is recognized on the cellular and humoral level by patients with Yersinia induced reactive arthritis. , 1999, The Journal of rheumatology.
[155] D. Resnick. Diagnosis of Bone and Joint Disorders , 1987 .
[156] R. Inman,et al. ME1 epitope of HLA-B27 confers class I-mediated modulation of gram-negative bacterial invasion. , 1994, Journal of immunology.
[157] Y. Konttinen,et al. The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis. , 1992, Arthritis and rheumatism.
[158] R. Hughes,et al. Antigen-presenting cells but not lymphocytes in the joint may indicate the cause of reactive arthritis. , 1996, British journal of rheumatology.
[159] E. Märker-Hermann,et al. The cutting edge of spondylarthropathy research in the millennium. , 2002, Arthritis and rheumatism.
[160] R. Inman,et al. Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis. , 1988, Arthritis and rheumatism.
[161] P. Galle,et al. IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients. , 2001, Arthritis and rheumatism.
[162] A. Toivanen,et al. Two forms of reactive arthritis? , 1999, Annals of the rheumatic diseases.
[163] T. Yli-Kerttula,et al. Effect of antimicrobial treatment on chronic reactive arthritis. , 1993, Clinical and experimental rheumatology.
[164] I. Olivieri,et al. Retrocalcaneal bursitis in spondyloarthropathy: assessment by ultrasonography and magnetic resonance imaging. , 1998, The Journal of rheumatology.
[165] A. Toivanen,et al. Epidemiologic, clinical, and therapeutic aspects of reactive arthritis and ankylosing spondylitis. , 1995, Current opinion in rheumatology.
[166] P. Emery,et al. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. , 1999, Arthritis and rheumatism.
[167] M. Fiorillo,et al. CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. , 2000, The Journal of clinical investigation.
[168] L. Espinoza,et al. Detection of bacterial DNA in Latin American patients with reactive arthritis by polymerase chain reaction and sequencing analysis. , 2002, The Journal of rheumatology.
[169] A. Kantele,et al. Salmonella-specific antibodies in reactive arthritis. , 1991, The Journal of infectious diseases.
[170] E. Veys,et al. HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis. , 1985, The Journal of rheumatology.
[171] S. Jalkanen,et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. , 1989, The New England journal of medicine.
[172] H. Locht,et al. Reactive arthritis after Salmonella among medical doctors--study of an outbreak. , 1993, The Journal of rheumatology.
[173] L. Espinoza,et al. Reactive arthritis: newer developments. , 2003, Rheumatic diseases clinics of North America.
[174] J. Whittum-Hudson,et al. Chlamydia and associated arthritis , 2000, Current opinion in rheumatology.
[175] K. Mølbak,et al. High frequency of reactive joint symptoms after an outbreak of Salmonella enteritidis. , 2002, The Journal of rheumatology.
[176] J. Heesemann,et al. Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis. , 1990, Arthritis and rheumatism.
[177] R. Hammer,et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats , 1994, The Journal of experimental medicine.
[178] A. Toivanen,et al. IgA class antibodies against Yersinia enterocolitica O:3 in patients with thyroid disease. , 1988, Acta endocrinologica.
[179] R. Inman,et al. HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells. , 1992, Journal of immunology.
[180] U. DeBellis. Reiter's disease. , 1952, British medical journal.
[181] P. Toivanen,et al. What determines arthritogenicity of bacterial cell wall? A study on Eubacterium cell wall-induced arthritis. , 2000, Rheumatology.
[182] M. Weisman,et al. The physician Hans Reiter as prisoner of war in Nuremberg: a contextual review of his interrogations (1945-1947). , 2003, Seminars in arthritis and rheumatism.
[183] L. Boyle,et al. Breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies. , 2003, Rheumatology.
[184] F. Hiepe,et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. , 1999, Arthritis and rheumatism.
[185] D. Reda,et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study. , 1996, Arthritis and rheumatism.
[186] L. Hoenig. The arthritis of Christopher Columbus. , 1992, Archives of internal medicine.
[187] T. Vischer,et al. Chlamydial Serology: Comparative Diagnostic Value of Immunoblotting, Microimmunofluorescence Test, and Immunoassays Using Different Recombinant Proteins as Antigens , 2001, Journal of Clinical Microbiology.
[188] M. Neurath,et al. T cell specificity and cross reactivity towards enterobacteria,Bacteroides,Bifidobacterium, and antigens from resident intestinal flora in humans , 1999, Gut.
[189] J. Heesemann,et al. Yersinia enterocolitica Impairs Activation of Transcription Factor NF-κB: Involvement in the Induction of Programmed Cell Death and in the Suppression of the Macrophage Tumor Necrosis Factor α Production , 1998, The Journal of experimental medicine.
[190] T. Vischer,et al. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. , 1995, Arthritis and rheumatism.
[191] H. Dienes,et al. Enterobacteria-infected T cells as antigen-presenting cells for cytotoxic CD8 T cells: a contribution to the self-limitation of cellular immune reactions in reactive arthritis? , 1997, The Journal of infectious diseases.
[192] G. Peltz,et al. Pathogen antigen- and superantigen-reactive synovial fluid T cells in reactive arthritis. , 1995, The Journal of infectious diseases.
[193] H. Jasin. Bacterial lipopolysaccharides induce in vitro degradation of cartilage matrix through chondrocyte activation. , 1983, The Journal of clinical investigation.
[194] R. Patterson,et al. Coronary artery stenosis in Reiter's syndrome: a complication of aortitis. , 1994, The Journal of rheumatology.
[195] L. Laasonen,et al. Infectious background of patients with a history of acute anterior uveitis , 2002, Annals of the rheumatic diseases.
[196] J. Braun,et al. Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. , 2002, Arthritis and rheumatism.
[197] C. Ritchlin,et al. Recent advances in the treatment of the seronegative spondyloarthropathies , 2001, Current rheumatology reports.
[198] G. Kingsley,et al. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. , 2000, The Journal of rheumatology.
[199] G. Kingsley,et al. Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts. , 1996, Annals of the rheumatic diseases.
[200] D. Wallace,et al. Should a war criminal be rewarded with eponymous distinction?: the double life of hans reiter (1881-1969). , 2000, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[201] M. Helfand,et al. Screening for chlamydial infection. , 2001, American journal of preventive medicine.
[202] J. Heesemann,et al. Invasion and persistence of Salmonella in human fibroblasts positive or negative for endogenous HLA B27 , 1997, Annals of the rheumatic diseases.
[203] D. Allison. CHRISTOPHER COLUMBUS: FIRST CASE OF REITER'S DISEASE IN THE OLD WORLD? , 1980, The Lancet.
[204] R. Cuchacovich,et al. Applications of polymerase chain reaction in rheumatology. , 2003, Rheumatic diseases clinics of North America.
[205] R. Colbert,et al. HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum? , 2000, Molecular medicine today.
[206] A. Bengtsson,et al. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. , 1990, BMJ.
[207] R. Lahesmaa,et al. Molecular mimickry between HLA B27 and Yersinia, Salmonella, Shigella and Klebsiella within the same region of HLA α1‐helix , 1991, Clinical and experimental immunology.
[208] A. Toivanen,et al. Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. , 1980, The Journal of infectious diseases.
[209] W. Barth,et al. Reactive arthritis (Reiter's syndrome). , 1999, American family physician.
[210] O. Oniankitan,et al. Spondyloarthropathies in sub-Saharan Africa , 2000, Current Opinion in Rheumatology.
[211] B. Thomas,et al. CHLAMYDIA TRACHOMATIS AND REACTIVE ARTHRITIS: THE MISSING LINK , 1987, The Lancet.
[212] B. Thomas,et al. Laboratory techniques for the diagnosis of chlamydial infections. , 1991, Genitourinary medicine.
[213] J. Gaston,et al. Clinical and experimental evidence for persistent Yersinia infection in reactive arthritis. , 1999, Arthritis and rheumatism.
[214] J. Angulo,et al. The spectrum of skin, mucosa and other extra-articular manifestations. , 1998, Bailliere's clinical rheumatology.
[215] M. Poca,et al. Reactive arthritis with a severe lesion of the cervical spine. , 1997, British journal of rheumatology.
[216] M. Tamulaitienė,et al. A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis. , 1999, Rheumatology.
[217] H. Luthra,et al. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies , 1995, The Journal of experimental medicine.
[218] P. Davis,et al. The sacroiliitis of acute Reiter's syndrome. , 1977, The Journal of rheumatology.
[219] J. Heesemann,et al. Yersinia enterocolitica: a cause of chronic polyarthritis. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[220] S Gary Firestein,et al. Kelley's Textbook of Rheumatology , 2004 .
[221] R. Hughes,et al. Reiter's Syndrome and Reactive Arthritis: A , 1994 .
[222] J. Reveille,et al. HLA-B27 and genetic predisposing factors in spondyloarthropathies , 2001, Current opinion in rheumatology.
[223] Hongwei H Zhang,et al. Tumor Necrosis Factor Receptor p55-Deficient Mice Respond to Acute Yersinia enterocolitica Infection with Less Apoptosis and More Effective Host Resistance , 2000, Infection and Immunity.
[224] J. Goronzy,et al. Immune responses to Borrelia burgdorferi in patients with reactive arthritis. , 1989, Arthritis and rheumatism.
[225] A. Calin,et al. Reiter's syndrome: Evaluation of preliminary criteria for definite disease , 1982 .